Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045
Zhen Ling Teo,Yih-Chung Tham,Marco Yu,Miao Li Chee,Tyler Hyungtaek Rim,Ning Cheung,Mukharram M Bikbov,Ya Xing Wang,Yating Tang,Yi Lu,Ian Y Wong,Daniel Shu Wei Ting,Gavin Siew Wei Tan,Jost B Jonas,Charumathi Sabanayagam,Tien Yin Wong,Ching-Yu Cheng,Mukharram M. Bikbov,Ian Y. Wong,Jost B. Jonas
DOI: https://doi.org/10.1016/j.ophtha.2021.04.027
IF: 14.277
2021-11-01
Ophthalmology
Abstract:TOPIC: To provide updated estimates on the global prevalence and number of people with diabetic retinopathy (DR) through 2045.CLINICAL RELEVANCE: The International Diabetes Federation (IDF) estimated the global population with diabetes mellitus (DM) to be 463 million in 2019 and 700 million in 2045. Diabetic retinopathy remains a common complication of DM and a leading cause of preventable blindness in the adult working population.METHODS: We conducted a systematic review using PubMed, Medline, Web of Science, and Scopus for population-based studies published up to March 2020. Random effect meta-analysis with logit transformation was performed to estimate global and regional prevalence of DR, vision-threatening DR (VTDR), and clinically significant macular edema (CSME). Projections of DR, VTDR, and CSME burden were based on population data from the IDF Atlas 2019.RESULTS: We included 59 population-based studies. Among individuals with diabetes, global prevalence was 22.27% (95% confidence interval [CI], 19.73%-25.03%) for DR, 6.17% (95% CI, 5.43%-6.98%) for VTDR, and 4.07% (95% CI, 3.42%-4.82%) for CSME. In 2020, the number of adults worldwide with DR, VTDR, and CSME was estimated to be 103.12 million, 28.54 million, and 18.83 million, respectively; by 2045, the numbers are projected to increase to 160.50 million, 44.82 million, and 28.61 million, respectively. Diabetic retinopathy prevalence was highest in Africa (35.90%) and North American and the Caribbean (33.30%) and was lowest in South and Central America (13.37%). In meta-regression models adjusting for habitation type, response rate, study year, and DR diagnostic method, Hispanics (odds ratio [OR], 2.92; 95% CI, 1.22-6.98) and Middle Easterners (OR, 2.44; 95% CI, 1.51-3.94) with diabetes were more likely to have DR compared with Asians.DISCUSSION: The global DR burden is expected to remain high through 2045, disproportionately affecting countries in the Middle East and North Africa and the Western Pacific. These updated estimates may guide DR screening, treatment, and public health care strategies.
ophthalmology